OSI, Pfizer Say Breckenridge Infringed Cancer Drug Patents
OSI Pharmaceuticals LLC and Pfizer Inc. on Tuesday accused Breckenridge Pharmaceutical Inc. in Delaware federal court of infringing two of its patents related to the cancer drug Tarceva....To view the full article, register now.
Already a subscriber? Click here to view full article